Although things were winding down in Vienna, Friday was definitely a case of last but not least for type 1 research. Potential cures were at the forefront of the day’s lectures, with a particular focus on encapsulation and immune therapies – two big areas in which JDRF is investing.
Continue reading “A view from Vienna, day 5: Looking to the future”
It’s hard to believe that the JDRF Artificial Pancreas Program was launched only eight years ago. Since then, we’ve gone from a few prototype devices being used by one or two people, to three-week and three-month trials of the artificial pancreas at home, unsupervised by researchers.
But as exciting and as close to reality the first generation devices are now, we’re not resting on our laurels. Thursday’s presentations from researchers focused on all elements of the artificial pancreas – CGMs, pumps and the algorithm – and how we can get the most from them.
Continue reading “A view from Vienna, day 4: Type 1 tech and treatments”
While a lot of the research we fund at JDRF is working towards a cure, we also want to help people who have type 1 to live longer, healthier lives until the cure is found. That’s why we fund a number of projects looking at preventing and treating complications, alongside work to make controlling glucose levels safer and easier. And from Wednesday’s sessions at EASD it’s clear we’re not alone in this: researchers from around the world were here to discuss their work on understanding diabetes complications.
Continue reading “A view from Vienna, day 3: Making diabetes complications less complicated”
Tuesday was the first day of the conference proper, with scientific presentations and announcements beginning in earnest.
In the morning, talks chaired by Professor Simon Heller of the University of Sheffield emphasised the importance of diabetes education – something that JDRF is also committed to highlighting. Continue reading “A view from Vienna, day 2: Education, education, education”
On Monday, JDRF held a discussion that drew in experts from around the world. Entitled ‘The Role of Infant Diet in Susceptibility/Resistance to Type 1 Diabetes’, it looked for answers to a big question in type 1 diabetes research – can we run a study to explore the influence that a child’s diet has on their risk of developing the condition?
Continue reading “A view from Vienna, day 1: Infant diet and type 1 diabetes”
Conor McKeever 